Metabolomics, Microbiomics, Machine learning during the COVID-19 pandemic
Fanos V.Last
2022-01-01
Abstract
COVID-19 pandemic has a significant impact worldwide, from the point of view of public health, social, and economic aspects. The correct strategies of diagnosis and global management are still under debate. In the next future, we firmly believe that combining the so-called 3 M's (metabolomics, microbiomics, and machine learning [artificial intelligence]) will be the optimal, accurate tool for the early diagnosis of COVID-19 subjects, risk assessment and stratification, patient management, and decision-making. If the currently available preliminary data obtain further confirms, through future studies on larger samples, simple biomarkers will provide predictive models for data analysis and interpretation, allowing a step toward personalized holistic medicine.File | Size | Format | |
---|---|---|---|
Pediatric Allergy Immunology - 2022 - Bardanzellu - Metabolomics Microbiomics Machine learning during the COVID‐19.pdf open access
Type: versione editoriale
Size 176.52 kB
Format Adobe PDF
|
176.52 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.